HVAX Technologies Limited Invests in Krew Instruments Private Limited

HVAX Technologies Limited Invests in Krew Instruments Private Limited

HVAX Technologies Limited Invests in Krew Instruments Private Limited​

HVAX Technologies Limited announced on March 26, 2026, that its Board of Directors approved an investment in Krew Instruments Private Limited, a company operating in the hospital domain. The investment includes a subscription to a private placement of equity shares and a transfer of shares, totaling Rs. 1,05,00,000.

The company will subscribe to up to 15,000 equity shares of Rs. 700 each, with a face value of Rs. 10 per share and a premium of Rs. 690 per share. Additionally, HVAX Technologies Limited will transfer up to 5,000 equity shares of Rs. 700 each. The total consideration will be paid in cash.

Following the transaction, Krew Instruments Private Limited will become a subsidiary of HVAX Technologies Limited, controlling 80% of the investment in equity shares. The acquisition is anticipated to be completed within 15 days.

Krew Instruments Private Limited, incorporated on April 2, 2018, reported an annual turnover of Rs. 2.61 crore with a profit after tax of 9% for fiscal year 2025. Its registered office is located in Thane, Maharashtra. Key promoters of Krew Instruments Private Limited are Biju Gopalkrishnan Unnithan and Bindu Biju Unnithan. The company's product lines include Blood Bank Equipment, Pharma Equipment, and Laboratory & Healthcare Equipment. The acquisition is expected to create synergy through cross-selling opportunities, aligning with existing customer requirements.



Table: Details of the Acquisition

ParticularsDetails
Name of Target EntityKrew Instruments Private Limited (FY 2025 turnover: Rs. 2.61 crore, PAT: 9%)
Related Party TransactionNot a related party transaction
IndustryHospital & Laboratory segment
Objects and Impact of AcquisitionSynergy through cross-selling opportunities
Governmental or Regulatory ApprovalsNot applicable
Indicative Time Period for CompletionWithin 15 days
ConsiderationCash
Cost of Acquisition (Equity Shares)15,000 equity shares of Rs. 700 each & 5,000 equity shares of Rs. 700 each
Shareholding/Control Acquired80%
Date of IncorporationApril 2, 2018
Registered OfficeRoom No. 4/1101, Niraj Park, Wayle Nagar, Khadakpada, Thane, Kalyan, Maharashtra 421301
PromotersBiju Gopalkrishnan Unnithan & Bindu Biju Unnithan
Product LinesBlood Bank Equipment, Pharma Equipment, Laboratory & Healthcare Equipment

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top